These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2111625)

  • 1. Cervical screening revisited.
    van der Graaf Y; Vooijs GP; Zielhuis GA
    Acta Cytol; 1990; 34(3):366-72. PubMed ID: 2111625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical cancer screening programs: summary of the 1982. Canadian task force report.
    Can Med Assoc J; 1982 Oct; 127(7):581-9. PubMed ID: 7127225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of cervical screening in Australia: what is the impact of screening at different intervals or over a different age range?
    Anderson R; Haas M; Shanahan M
    Aust N Z J Public Health; 2008 Feb; 32(1):43-52. PubMed ID: 18290913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R; Budukh AM; Rajkumar R
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan.
    Koong SL; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S44-7. PubMed ID: 17227642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
    Kim JJ; Leung GM; Woo PP; Goldie SJ
    J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety net: a cost-effective approach to improving breast and cervical cancer screening.
    Vogt TM; Glass A; Glasgow RE; La Chance PA; Lichtenstein E
    J Womens Health (Larchmt); 2003 Oct; 12(8):789-98. PubMed ID: 14588129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening.
    Thiry N; De Laet C; Hulstaert F; Neyt M; Huybrechts M; Cleemput I
    Int J Technol Assess Health Care; 2009 Apr; 25(2):161-70. PubMed ID: 19366497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
    Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
    Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of quality assurance in an organized cervical screening program.
    Andrae B; Smith P
    Acta Obstet Gynecol Scand; 1999 May; 78(5):429-35. PubMed ID: 10326890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for cervical carcinoma.
    van Leeuwen AW; de Nooijer P; Hop WC
    Cancer; 2005 Oct; 105(5):270-6. PubMed ID: 15937918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands.
    Coupé VM; de Melker HE; Snijders PJ; Meijer CJ; Berkhof J
    Vaccine; 2009 Aug; 27(37):5111-9. PubMed ID: 19567242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Population screening for uterine cervix cancer: the negative effects of insufficient knowledge as to what is normal and abnormal].
    van der Graaf Y
    Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1569-71. PubMed ID: 12224477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Criteria for organized cervical screening programs. Special emphasis on The Netherlands program.
    Hanselaar AG
    Acta Cytol; 2002; 46(4):619-29. PubMed ID: 12146020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National registry of cervical cytologic diagnoses in The Netherlands.
    Vooijs GP; Casparie-van Velsen IA; Peters FA; Beck HL
    Acta Cytol; 1989; 33(6):825-30. PubMed ID: 2588915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer control in developing countries: memorandum from a WHO meeting.
    Bull World Health Organ; 1996; 74(4):345-51. PubMed ID: 8823955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
    Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC
    Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and detection of cervical cancer. Implementing the national screening policy.
    Guest C; Griffith E; Lewis SY; Moulding N
    Aust Fam Physician; 1996 Nov; 25(11):1722-30. PubMed ID: 8952107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.